HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Simon P Fletcher Selected Research

Interferon-alpha (Interferon Alfa)

9/2015Intrahepatic Transcriptional Signature Associated with Response to Interferon-α Treatment in the Woodchuck Model of Chronic Hepatitis B.
3/2014Immune cell responses are not required to induce substantial hepatitis B virus antigen decline during pegylated interferon-alpha administration.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Simon P Fletcher Research Topics

Disease

23Chronic Hepatitis B
05/2024 - 05/2013
19Infections
05/2024 - 09/2005
4Hepatitis B
11/2023 - 01/2017
2Chronic Hepatitis C
01/2012 - 09/2005
1Hepatitis
02/2024
1Coinfection
01/2023
1Nausea
01/2023
1Respiratory Tract Infections (Respiratory Tract Infection)
01/2023
1Vomiting
01/2023
1Reinfection
01/2022
1Inflammation (Inflammations)
01/2019
1Thrombocytopenia (Thrombopenia)
06/2015

Drug/Important Bio-Agent (IBA)

7selgantolimodIBA
05/2024 - 01/2020
7InterferonsIBA
01/2023 - 01/2012
6RNA (Ribonucleic Acid)IBA
05/2024 - 01/2012
6Hepatitis B Surface Antigens (HBsAg)FDA Link
11/2023 - 01/2021
5Toll-Like Receptor 8IBA
05/2024 - 01/2020
5Antiviral Agents (Antivirals)IBA
02/2024 - 01/2013
4CytokinesIBA
11/2023 - 09/2012
4Toll-Like Receptor 7IBA
01/2018 - 01/2012
3DNA (Deoxyribonucleic Acid)IBA
02/2024 - 01/2022
3AntigensIBA
04/2023 - 03/2014
3vesatolimodIBA
01/2018 - 06/2015
2Proteins (Proteins, Gene)FDA Link
01/2023 - 01/2017
2Circular DNAIBA
01/2023 - 01/2022
2NucleotidesIBA
01/2019 - 05/2013
2hepatitis B virus X proteinIBA
01/2019 - 01/2017
2Interferon-alpha (Interferon Alfa)IBA
09/2015 - 03/2014
1Conditioned Culture MediaIBA
05/2024
1tenofovir alafenamideIBA
02/2024
1Alanine Transaminase (SGPT)IBA
02/2024
1Differentiation AntigensIBA
11/2023
1Transcription Factors (Transcription Factor)IBA
11/2023
1Biomarkers (Surrogate Marker)IBA
04/2023
1nasIBA
01/2023
1Hepatitis B e AntigensIBA
01/2023
1Hepatitis delta Antigens (HDAg)IBA
01/2023
1Surface Antigens (Surface Antigen)IBA
01/2022
1LipidsIBA
01/2022
1Lipoproteins (Lipoprotein)IBA
01/2022
1myrcludex-BIBA
01/2022
1Viral ProteinsIBA
01/2019
1EnzymesIBA
06/2015
1NucleosidesIBA
05/2013
1Interferon Type IIBA
09/2012
1Toll-Like Receptors (Toll-Like Receptor)IBA
01/2012
1ProdrugsIBA
01/2012
1isatoribineIBA
09/2005

Therapy/Procedure

10Therapeutics
02/2024 - 09/2005
1Aftercare (After-Treatment)
05/2013
1Ligation
01/2012